Lymphoproliferative skin lesion as a previously unreported adverse event detected in a patient receiving mSTR TB treatment. jpadr [Internet]. 2022 Jun. 1 [cited 2026 Nov. 12];3(2):34-7. Available from: http://jpadr.com/index.php/jpadr/article/view/62